Listed

Groupon, Inc.

GRPNNasdaqCIK 1490281IndustrialsFiscal year ends Dec 31

Reports and events: 285 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Groupon, Inc., Reports and events
FiledFormWhat it isAccession number
2026-08-1016:30 ETSCHEDULE 13D/AOwnership report, active investor, amended0000921895-26-002024
2026-08-0616:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-054320
2026-08-0616:11 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-054304
2026-06-1716:05 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001490281-26-000021
2026-06-0809:03 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001490281-26-000016
2026-05-2608:00 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001490281-26-000013
2026-05-0716:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-032154
2026-05-0716:14 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-032124
2026-04-3017:43 ETSCHEDULE 13D/AOwnership report, active investor, amended0000921895-26-001125
2026-04-2816:05 ETDEF 14AProxy statementPeriod 2026-06-110001490281-26-000009
2026-03-1016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-016436
2026-03-1016:14 ET10-KAnnual reportPeriod 2025-12-310001628280-26-016429
2025-12-3108:20 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628280-25-059158
2025-12-0808:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-25-055717
2025-11-0616:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-050198
2025-11-0616:15 ET10-QQuarterly reportPeriod 2025-09-300001628280-25-050187
2025-08-0616:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-25-000040
2025-08-0616:12 ET10-QQuarterly reportPeriod 2025-06-300001490281-25-000039
2025-07-0217:21 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-25-034072
2025-06-1807:29 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001490281-25-000027
2025-06-1618:29 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001628280-25-031403
2025-05-0716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-25-000018
2025-05-0716:11 ET10-QQuarterly reportPeriod 2025-03-310001490281-25-000017
2025-04-2816:07 ETDEF 14AProxy statementPeriod 2024-12-310001490281-25-000010
2025-03-1116:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-25-000006
2025-03-1116:12 ET10-KAnnual reportPeriod 2024-12-310001490281-25-000005
2025-02-0616:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0000921895-25-000275
2024-12-1008:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001490281-24-000136
2024-11-1916:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001490281-24-000131
2024-11-1216:51 ET10-QQuarterly reportPeriod 2024-09-300001628280-24-047250
2024-11-1216:50 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-24-047241
2024-11-0116:29 ETSC 13D/AOwnership report, active investor, amended0000921895-24-002431
2024-07-3016:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-24-000123
2024-07-3016:18 ET10-QQuarterly reportPeriod 2024-06-300001490281-24-000122
2024-06-1217:18 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001490281-24-000099
2024-05-1017:49 ETSC 13D/AOwnership report, active investor, amended0000921895-24-001125
2024-05-0917:28 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001490281-24-000089
2024-05-0916:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-24-000088
2024-05-0916:06 ET10-QQuarterly reportPeriod 2024-03-310001490281-24-000087
2024-05-0709:26 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001490281-24-000069
2024-04-2917:25 ETDEF 14AProxy statementPeriod 2023-12-310001490281-24-000060
2024-04-1517:23 ET8-K8.01 Other events0001490281-24-000039
2024-04-0109:00 ET8-K5.02 Departure or appointment of officers or directors0001490281-24-000034
2024-03-1507:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-24-000025
2024-03-1506:58 ET10-KAnnual reportPeriod 2023-12-310001490281-24-000024
2024-02-1519:29 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001490281-24-000016
2024-01-2316:40 ETSC 13D/AOwnership report, active investor, amended0000921895-24-000113
2024-01-2208:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001490281-24-000006
2024-01-1208:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001490281-24-000004
2023-11-2116:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001490281-23-000131

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.